© Copyright 2025 American Medical Association. All rights reserved.
The procedure described by CPT® Code 51030 involves a cystotomy or cystostomy, which is a surgical intervention performed on the urinary bladder. In this procedure, the urinary bladder is either fully exposed and incised or accessed through a smaller incision made over the bladder, where the bladder wall is punctured to allow entry into the internal lumen. This access is crucial for the subsequent treatment of intravesical lesions, which are abnormal growths or tissues located within the bladder. The primary technique utilized in this procedure is cryosurgical destruction, where a cryoprobe is introduced through the incision to freeze the abnormal tissue. This freezing process effectively destroys the targeted lesions. It is important to note that multiple freeze-thaw cycles may be necessary to ensure complete destruction of all abnormal tissue. This method is an alternative to other techniques such as fulguration or the insertion of radioactive materials, which are also used to treat similar lesions within the bladder. The choice of technique depends on the specific characteristics of the lesion and the overall treatment plan for the patient.
© Copyright 2025 Coding Ahead. All rights reserved.
The procedure described by CPT® Code 51030 is indicated for the treatment of intravesical lesions within the urinary bladder. These lesions may include abnormal growths or tissues that require surgical intervention to prevent complications such as obstruction, bleeding, or progression to malignancy. The specific indications for performing a cystotomy or cystostomy with cryosurgical destruction may include:
The procedure for CPT® Code 51030 involves several critical steps to ensure effective treatment of the intravesical lesions. The following procedural steps are outlined:
After the completion of the cystotomy or cystostomy with cryosurgical destruction, post-procedure care is essential for patient recovery. Patients may be monitored for any immediate complications, such as bleeding or infection. It is also important to assess urinary function and ensure that the bladder is healing properly. Follow-up appointments may be scheduled to evaluate the success of the procedure and to monitor for any recurrence of lesions. Patients may be advised on hydration and urinary habits to promote healing and prevent complications. Additionally, any specific instructions regarding activity restrictions or medication management should be provided to ensure optimal recovery.
| Short Descr | INCISE & TREAT BLADDER | Medium Descr | CSTOTOMY/CSTOST CRYOSURG DSTRJ INTRAVESICAL LES | Long Descr | Cystotomy or cystostomy; with cryosurgical destruction of intravesical lesion | Status Code | Active Code | Global Days | 090 - Major Surgery | PC/TC Indicator (26, TC) | 0 - Physician Service Code | Multiple Procedures (51) | 2 - Standard payment adjustment rules for multiple procedures apply. | Bilateral Surgery (50) | 0 - 150% payment adjustment for bilateral procedures does NOT apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 0 - Payment restriction for assistants at surgery applies to this procedure... | Co-Surgeons (62) | 0 - Co-surgeons not permitted for this procedure. | Team Surgery (66) | 0 - Team surgeons not permitted for this procedure. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | APC Status Indicator | Hospital Part B services paid through a comprehensive APC | Type of Service (TOS) | 2 - Surgery | Berenson-Eggers TOS (BETOS) | P1G - Major procedure - Other | MUE | Not applicable/unspecified. | CCS Clinical Classification | 112 - Other OR therapeutic procedures of urinary tract |
|
Date
|
Action
|
Notes
|
|---|---|---|
| 2024-12-31 | Deleted | Code Deleted. |
| Pre-1990 | Added | Code added. |